Abstract
STAT3 hyper-IgE syndrome (STAT3-HIES) patients presented with significantly lower Staphylococcus aureus-specific serum IgG compared to cystic fibrosis patients despite recurrent S. aureus infections. Immunoglobulin replacement therapy increased S. aureus-specific IgG in STAT3-HIES patients and attenuated the clinical course of disease suggesting a role of humoral immunity in S. aureus clearance.
| Original language | English |
|---|---|
| Pages (from-to) | 1279-1282 |
| Number of pages | 4 |
| Journal | Clinical Infectious Diseases |
| Volume | 64 |
| Issue number | 9 |
| DOIs | |
| State | Published - 1 May 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adaptive immunity
- Cystic fibrosis
- HIES
- Hyper-IgE Syndrome
- S. aureus
- STAT3
- Specific IgG
- Th17
Fingerprint
Dive into the research topics of 'Reduced immunoglobulin (Ig) G response to Staphylococcus aureus in STAT3 hyper-IgE syndrome'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver